Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 65
Filtrer
1.
Clin Lab ; 70(6)2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38868875

RÉSUMÉ

BACKGROUND: Invasive pulmonary aspergillosis (IPA) is a deep fungal infection caused by invasion of Aspergillus mycelium into the lung parenchyma resulting in tissue destruction and necrosis, which occurs more often in im-munosuppressed populations. The severity of the disease and the rapid progression of the lung lesions puts pa¬tients at high risk of death and poor prognosis if the correct therapeutic intervention is not given as early as possible. METHODS: Here we report a case of IPA, which was initially diagnosed as community-acquired pneumonia in a local hospital. The symptoms did not improve after receiving anti-infective treatment. The patient was diagnosed with IPA after completing a chest CT examination and an electronic bronchoscopy, as well as pathogenetic examination of the bronchoalveolar lavage fluid and pathological examination of the left bronchial mass in the respiratory department of our hospital, which was finally diagnosed as IPA. After one week of administration of voriconazole for anti-fungal infection treatment, the patient's symptoms improved significantly, and a repeat chest CT suggested that the lung lesions were better than before. In order to raise clinicians' awareness of this disease, we also conducted a literature analysis. RESULTS: The final diagnosis of IPA was made by analyzing the patient's history, symptoms, signs, and relevant findings. CONCLUSIONS: When the patient's clinical symptoms and imaging manifestations are consistent with IPA, electronic bronchoscopy and pathogenetic and pathological examinations may be appropriately performed to clarify the na-ture of the lesion. More consideration should be given to the possibility of disease diagnosis to avoid misdiagnosis and underdiagnosis. Appropriate treatment should be given at an early stage.


Sujet(s)
Antifongiques , Aspergillose pulmonaire invasive , Tomodensitométrie , Voriconazole , Humains , Aspergillose pulmonaire invasive/diagnostic , Aspergillose pulmonaire invasive/traitement médicamenteux , Aspergillose pulmonaire invasive/microbiologie , Antifongiques/usage thérapeutique , Voriconazole/usage thérapeutique , Bronchoscopie , Mâle , Liquide de lavage bronchoalvéolaire/microbiologie , Adulte d'âge moyen , Poumon/imagerie diagnostique , Poumon/microbiologie , Poumon/anatomopathologie
2.
Clin Lab ; 70(6)2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38868881

RÉSUMÉ

BACKGROUND: IgG4-related disease (IgG4-RD) is an immune-mediated systemic inflammatory fibrotic disease, which is a relatively rare and novel disease that can involve multiple organs or tissues, with variable clinical manifestations, and for which pulmonary involvement has been reported relatively infrequently. METHODS: Here we report a case of pulmonary infection that was initially suspected and received anti-inflammatory treatment, but the symptoms did not improve. CT examination indicated progression of the pulmonary lesion, and the nature of the lesion could not be determined by tracheoscopy and bronchoalveolar lavage. The diagnosis of IgG4 related lung disease (IgG4-RLD) was confirmed by percutaneous lung biopsy. A joint literature analysis was conducted to improve clinicians' understanding of this disease. RESULTS: The patient's history, symptoms, signs and relevant examination results were analyzed. The final diagnosis was IgG4-RLD. CONCLUSIONS: When the clinical symptoms and imaging manifestations of the patients are consistent with IgG4-RLD, pathological examination can be appropriately performed to clarify the nature of the lesions. More consideration should be given to the possibility of disease diagnosis to avoid misdiagnosis and underdiagnosis, and proper treatment should be given at an early stage.


Sujet(s)
Maladie associée aux immunoglobulines G4 , Immunoglobuline G , Maladies pulmonaires , Tomodensitométrie , Humains , Maladie associée aux immunoglobulines G4/diagnostic , Maladie associée aux immunoglobulines G4/immunologie , Maladies pulmonaires/diagnostic , Maladies pulmonaires/immunologie , Immunoglobuline G/sang , Immunoglobuline G/immunologie , Mâle , Poumon/imagerie diagnostique , Poumon/anatomopathologie , Poumon/immunologie , Adulte d'âge moyen , Biopsie
3.
Clin Lab ; 70(6)2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38868879

RÉSUMÉ

BACKGROUND: Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus type 2, which is characterized by high infectiousness and diverse clinical manifestations. They are more likely to become critical in people who have underlying diseases or are immunocompromised. In the daunting task of treating patients with COVID-19, those with comorbid fungal infections are susceptible to underdiagnosis or misdiagnosis, which can ultimately lead to increased morbidity and mortality in this group of patients. We report a case of intrapulmonary cavitary lesions after COVID-19, which was eventually diagnosed as pulmonary aspergillosis (PA) by metagenomic Next Generation Sequencing (mNGS) to improve our understanding of the disease. METHODS: Appropriate laboratory tests, chest computed tomography (CT), mNGS, and serologic tests were performed for diagnosis. RESULTS: Laboratory tests showed Glactomannan (GM) of 1.41, multiple cavitary lesions in both lungs on chest CT and the presence of aspergillus infection was confirmed by sputum sent for mNGS. CONCLUSIONS: In the case of cavitary lesions after COVID-19, we should be alert to the possibility of combined fungi and should promptly perform mNGS to clarify whether there is a combination of specific pathogenic fungal infections.


Sujet(s)
COVID-19 , Aspergillose pulmonaire , Tomodensitométrie , Humains , COVID-19/complications , COVID-19/diagnostic , Aspergillose pulmonaire/diagnostic , Aspergillose pulmonaire/complications , Mâle , SARS-CoV-2/isolement et purification , Poumon/imagerie diagnostique , Poumon/microbiologie , Adulte d'âge moyen , Séquençage nucléotidique à haut débit , Métagénomique/méthodes , Femelle
4.
Clin Lab ; 70(6)2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38868889

RÉSUMÉ

BACKGROUND: Reactivation of cytomegalovirus is more common in lymphoma patients undergoing hematopoietic stem cell transplantation, but reactivation of cytomegalovirus due to chemotherapy for lymphoma has rarely been reported. We report a case of a lymphoma patient with secondary pulmonary fungal infection and cytomegalovirus infection after chemotherapy, which ultimately led to organizing pneumonia. METHODS: Percutaneous lung biopsy, Next Generation Sequencing (NGS). RESULTS: NGS examination suggestive of cytomegalovirus infection, percutaneous lung biopsy suggests the presence of organizing pneumonia. The patient was discharged after a combination of antifungal and antiviral treatment with posaconazole, ganciclovir, and anti-inflammatory treatment with methylprednisolone. CONCLUSIONS: In patients with lymphoma, one should be alert for fungal and viral infections of the lungs when lung related clinical manifestations occur. Patients with persistent unrelieved symptoms after treatment should undergo lung biopsy or bronchoscopy to obtain pathologic tissue for definitive diagnosis.


Sujet(s)
Infections à cytomégalovirus , Lymphomes , Humains , Infections à cytomégalovirus/complications , Infections à cytomégalovirus/diagnostic , Infections à cytomégalovirus/virologie , Lymphomes/complications , Mâle , Mycoses pulmonaires/diagnostic , Mycoses pulmonaires/traitement médicamenteux , Mycoses pulmonaires/microbiologie , Mycoses pulmonaires/complications , Antiviraux/usage thérapeutique , Antifongiques/usage thérapeutique , Adulte d'âge moyen , Cytomegalovirus/isolement et purification , Cytomegalovirus/génétique , Poumon/anatomopathologie , Poumon/imagerie diagnostique , Biopsie , Séquençage nucléotidique à haut débit , Pneumonie organisée
5.
Clin Lab ; 70(6)2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38868891

RÉSUMÉ

BACKGROUND: Non-tuberculous mycobacterial pulmonary infections (NTM-PD) are becoming increasingly common in clinical practice, and early detection and accurate determination of the infecting pathogen is crucial for subsequent treatment. We report a case of NTM-PD in a healthy middle-aged female with Mycobacterium tuberculosis complex group (MAC) infection confirmed by mNGS examination. METHODS: Appropriate laboratory tests, chest CT scan, bronchoscopic alveolar lavage fluid (BALF) examination, and macrogenomic next-generation sequencing (mNGS) were performed to establish the diagnosis. RESULTS: Chest CT showed multiple inflammatory lesions in the right middle lobe, and BALF sent for mNGS finally confirmed the diagnosis of MAC infection. After symptomatic treatment with azithromycin combined with ethambutol and rifampicin, the patient improved and was discharged from the hospital. CONCLUSIONS: In patients with pulmonary infections, pathogens should be clarified early to determine the diagnosis. mNGS of BALF samples have high specificity in detecting pathogens of infectious diseases, especially complex mixed infectious disease pathogens.


Sujet(s)
Liquide de lavage bronchoalvéolaire , Complexe Mycobacterium avium , Infection due à Mycobacterium avium-intracellulare , Humains , Femelle , Infection due à Mycobacterium avium-intracellulare/diagnostic , Infection due à Mycobacterium avium-intracellulare/microbiologie , Infection due à Mycobacterium avium-intracellulare/traitement médicamenteux , Infection due à Mycobacterium avium-intracellulare/complications , Complexe Mycobacterium avium/isolement et purification , Complexe Mycobacterium avium/génétique , Liquide de lavage bronchoalvéolaire/microbiologie , Adulte d'âge moyen , Tomodensitométrie , Séquençage nucléotidique à haut débit , Pneumopathie infectieuse/microbiologie , Pneumopathie infectieuse/diagnostic , Pneumopathie infectieuse/traitement médicamenteux , Azithromycine/usage thérapeutique , Rifampicine/usage thérapeutique
6.
Clin Lab ; 70(5)2024 May 01.
Article de Anglais | MEDLINE | ID: mdl-38747925

RÉSUMÉ

BACKGROUND: Post-transplant lymphoproliferative disorders are characterized by atypical clinical manifestations, high mortality, and missed diagnosis rates. METHODS: We report a case of renal transplantation in a patient with unexplained soft-tissue nodular shadows, and the type of the post-transplant abnormal soft-tissue shadows was clarified by puncture biopsy. RESULTS: The pathologic returns were consistent with the post-transplant lymphoproliferative disease, and the immunohistochemical returns supported a diffuse large B-cell lymphoma (non-growth center origin). CONCLUSIONS: In organ transplant patients, when unexplained soft tissue nodular shadows are present, the possibility of post-transplant lymphoproliferative disorders should be considered, and an aggressive puncture biopsy should be performed to clarify the diagnosis.


Sujet(s)
Transplantation rénale , Lymphome B diffus à grandes cellules , Humains , Transplantation rénale/effets indésirables , Lymphome B diffus à grandes cellules/diagnostic , Mâle , Adulte d'âge moyen , Biopsie
7.
Clin Lab ; 70(5)2024 May 01.
Article de Anglais | MEDLINE | ID: mdl-38747926

RÉSUMÉ

BACKGROUND: Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the normalization of COVID-19 globally, it is crucial to construct a prediction model that enables clinicians to identify patients at risk for ProLOS based on demographics and serum inflammatory biomarkers. METHODS: The study included hospitalized patients with a confirmed diagnosis of COVID-19. These patients were randomly grouped into a training (80%) and a test (20%) cohort. The LASSO regression and ten-fold cross-validation method were applied to filter variables. The training cohort utilized multifactorial logistic regression analyses to identify the independent factors of ProLOS in COVID-19 patients. A 4-variable nomogram was created for clinical use. ROC curves were plotted, and the area under the curve (AUC) was calculated to evaluate the model's discrimination; calibration analysis was planned to assess the validity of the nomogram, and decision curve analysis (DCA) was used to evaluate the clinical usefulness of the model. RESULTS: The results showed that among 310 patients with COVID-19, 80 had extended hospitalization (80/310). Four independent risk factors for COVID-19 patients were identified: age, coexisting chronic respiratory diseases, white blood cell count (WBC), and serum albumin (ALB). A nomogram based on these variables was created. The AUC in the training cohort was 0.808 (95% CI: 0.75 - 0.8671), and the AUC in the test cohort was 0.815 (95% CI: 0.7031 - 0.9282). The model demonstrates good calibration and can be used with threshold probabilities ranging from 0% to 100% to obtain clinical net benefits. CONCLUSIONS: A predictive model has been created to accurately predict whether the hospitalization duration of COVID-19 patients will be prolonged. This model incorporates serum WBC, ALB levels, age, and the presence of chronic respiratory system diseases.


Sujet(s)
COVID-19 , Durée du séjour , Nomogrammes , Humains , COVID-19/diagnostic , COVID-19/sang , COVID-19/épidémiologie , COVID-19/complications , Femelle , Mâle , Adulte d'âge moyen , Sujet âgé , Durée du séjour/statistiques et données numériques , Facteurs de risque , SARS-CoV-2 , Adulte , Courbe ROC , Hospitalisation , Études rétrospectives
8.
Clin Lab ; 70(5)2024 May 01.
Article de Anglais | MEDLINE | ID: mdl-38747927

RÉSUMÉ

BACKGROUND: Organizing pneumonia (OP) is a pathologic diagnosis with clinical and imaging manifestations that often resemble other diseases, such as infections and cancers, which can lead to delays in diagnosis and inappropriate management of the underlying disease. In this article, we present a case of organized pneumonia that resembles lung cancer. METHODS: We report a case of initial suspicion of pulmonary malignancy, treated with anti-inflammatory medication and then reviewed with CT suggesting no improvement, and finally confirmed to be OP by pathological biopsy taken via transbronchoscopy. A joint literature analysis was performed to raise clinicians' awareness of the diagnosis and treatment of OP. RESULTS: Initially, because of the atypical auxiliary findings, we thought that the disease turned out to be a lung tumor, which was eventually confirmed as OP by pathological diagnosis. CONCLUSIONS: The diagnosis and treatment of OP requires a combination of clinical information and radiological expertise, as well as biopsy to obtain histopathological evidence. That is, clinical-imaging-pathological tripartite cooperation and comprehensive analysis.


Sujet(s)
Tumeurs du poumon , Tomodensitométrie , Humains , Tumeurs du poumon/diagnostic , Tumeurs du poumon/anatomopathologie , Tumeurs du poumon/imagerie diagnostique , Diagnostic différentiel , Pneumonie organisée cryptogénique/diagnostic , Pneumonie organisée cryptogénique/anatomopathologie , Pneumonie organisée cryptogénique/imagerie diagnostique , Biopsie , Mâle , Sujet âgé , Adulte d'âge moyen , Poumon/anatomopathologie , Poumon/imagerie diagnostique , Bronchoscopie , Pneumonie organisée
9.
Clin Lab ; 70(3)2024 Mar 01.
Article de Anglais | MEDLINE | ID: mdl-38469771

RÉSUMÉ

BACKGROUND: Pulmonary tuberculosis (PTB) is an important infectious disease that threatens the health and life of human beings. In the diagnosis of PTB, imaging plays a dominant role, but due to the increasing drug resistance of Mycobacterium tuberculosis, atypical clinical manifestations, "different images with the same disease" or "different diseases with the same image" in chest imaging, and the low positivity rate of routine sputum bacteriology, which leads to a high rate of misdiagnosis of PTB. We report a case of pulmonary tuberculosis that was misdiagnosed on imaging. We report a case of pulmonary tuberculosis that resembled sarcoidosis on imaging and was negative for antacid staining on sputum smear and alveolar lavage fluid, and was later diagnosed by microbial next-generation sequencing (NGS). The case was initially misdiagnosed as sarcoidosis. METHODS: Alveolar lavage fluid NGS, chest CT, bronchoscopy. RESULTS: Chest CT showed multiple inflammatory lesions in both lungs, multiple nodular foci in both lungs, and multiple enlarged lymph nodes in the mediastinum and hilar region on both sides. Fiberoptic bronchoscopy was performed in the basal segment of the left lower lobe of the lungs to carry out bronchoalveolar lavage, and the lavage fluid was sent to the NGS test and returned the following results: Mycobacterium tuberculosis complex group detected in the number of sequences of 293. Based on the results of the NGS test, the diagnosis of pulmonary tuberculosis could be confirmed. CONCLUSIONS: The diagnosis of pulmonary tuberculosis cannot be easily excluded in patients with "different images with the same disease" or "different diseases with the same image" on chest imaging without the support of sputum positivity. The goal was to improve the alertness of medical personnel to the misdiagnosis of tuberculosis and the application of NGS technology.


Sujet(s)
Mycobacterium tuberculosis , Sarcoïdose , Tuberculose pulmonaire , Humains , Tuberculose pulmonaire/diagnostic , Tuberculose pulmonaire/microbiologie , Mycobacterium tuberculosis/génétique , Liquide de lavage bronchoalvéolaire/microbiologie , Sarcoïdose/diagnostic , Expectoration/microbiologie , Erreurs de diagnostic , Séquençage nucléotidique à haut débit , Sensibilité et spécificité
10.
Clin Lab ; 70(2)2024 Feb 01.
Article de Anglais | MEDLINE | ID: mdl-38345979

RÉSUMÉ

BACKGROUND: Carcinoembryonic antigen (CEA) is a polysaccharide complex that is found in the human respiratory system. It is of significant use in disease surveillance of lung cancer; however, serum CEA can occasionally only offer little assistance. We present a case of recurring infection initially diagnosed as carcinoembryonic antigen-negative in a patient with a history of hypersensitivity pneumonitis infection, which finally led to the diagnosis of lung adenocarcinoma following percutaneous lung puncture. METHODS: Appropriate laboratory tests, chest CT, bronchoscopy, percutaneous lung puncture, and pathologic examination were performed to explore the cause of the disease. RESULTS: Because CEA was negative and a chest CT showed interstitial changes in both lungs with numerous hyperdense shadows, coupled with the patient's history of hypersensitivity pneumonitis, we initially believed that the infection was relapsing. However, a percutaneous lung puncture eventually revealed that the patient had lung adenocarcinoma. CONCLUSIONS: Vigilance needs to be increased in clinical work for patients with interstitial lung disease, low tumor markers such as CEA, and imaging suggestive of inflammatory progression, which in fact turns into lung cancer. When the treatment is ineffective after standardized application of hormone and anti-infection, lung tissue should be obtained for pathological examination in time to obtain pathological evidence.


Sujet(s)
Adénocarcinome pulmonaire , Adénocarcinome , Alvéolite allergique extrinsèque , Tumeurs du poumon , Humains , Antigène carcinoembryonnaire , Récidive tumorale locale , Adénocarcinome pulmonaire/diagnostic , Tumeurs du poumon/anatomopathologie , Marqueurs biologiques tumoraux , Biopsie
11.
Clin Lab ; 70(1)2024 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-38213214

RÉSUMÉ

BACKGROUND: Patients with tuberculous empyema (TE) can have a serious impact on lung function as their disease progresses, and, if left untreated, can cause damage to other parts of the body such as the thorax and spine, causing pain and inconvenience to the patient. Early diagnosis and the search for appropriate treatment are key to improving the survival rate of the disease. METHODS: We report a case of a young patient with an unexpected finding of right pleural effusion on physical examination, who was eventually diagnosed with TE using next-generation sequencing of pleural tissue. We analyzed the literature to improve clinicians' understanding of TE and how to properly diagnose and treat the disease. RESULTS: Laboratory results of the pleural effusion suggested a possible Mycobacterium tuberculosis infection, but pathogen-related tests were negative, and the diagnosis was eventually successfully confirmed by thoracoscopic pleural biopsy. CONCLUSIONS: The diagnosis of TE should be considered in young patients with pleural thickening of the empyema. Adenosine deaminase may provide diagnostic direction in patients with unexplained thorax abscess. Pleural biopsy, although an invasive procedure, is an essential diagnostic tool in some cases.


Sujet(s)
Empyème tuberculeux , Épanchement pleural , Tuberculose pleurale , Humains , Empyème tuberculeux/diagnostic , Empyème tuberculeux/complications , Tuberculose pleurale/diagnostic , Tuberculose pleurale/anatomopathologie , Épanchement pleural/étiologie , Plèvre/anatomopathologie , Biopsie , Adenosine deaminase
12.
Clin Lab ; 70(1)2024 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-38213218

RÉSUMÉ

BACKGROUND: Herpesvirus IgG antibody positivity can be a lifelong burden of disease replication and reinfection or recent viruses can be reactivated and play an important role in the diagnosis and monitoring of herpesvirus [1]. However, sometimes serum IgG antibody positivity is of limited help in determining the onset of disease. We reported a case of herpesvirus IgG antibody positive in a patient with lung cancer who was initially misdiagnosed as herpes simplex and later confirmed drug-induced pemphigus (DIP) by histological and immunofluorescence studies. METHODS: Appropriate laboratory tests, enzyme-linked immunosorbent assay (ELISA), immunofluorescence and histological tests were performed for diagnosis. RESULTS: In lung cancer patients who were positive for herpesvirus IgG antibodies, were initially misdiagnosed as herpes simplex and eventually confirmed by histological and immunofluorescence examinations as DIP. CONCLUSIONS: Positive herpesvirus IgG antibody is not a specific manifestation of herpesvirus infection. For patients with unexplained skin blisters, we should improve histological examinations as soon as possible to clarify the type of lesion.


Sujet(s)
Herpès , Tumeurs du poumon , Pemphigus , Humains , Immunoglobuline G , Tumeurs du poumon/traitement médicamenteux , Technique d'immunofluorescence , Anticorps antiviraux , Test ELISA
13.
Clin Lab ; 69(11)2023 Nov 01.
Article de Anglais | MEDLINE | ID: mdl-37948488

RÉSUMÉ

BACKGROUND: Detection of serum neuron specific enolase (NSE) has high sensitivity and specificity in the diagnosis of lung cancer, especially small cell lung cancer, but sometimes serum NSE provides limited help. We report a case of high-density shadow of the left lung and elevated serum NSE which mimicked lung cancer. It was ultimately confirmed to be pulmonary aspergillosis (PA) by bronchoscopic alveolar lavage fluid (BALF) and next-generation sequencing (NGS). METHODS: Appropriate laboratory tests, chest computed tomography (CT) scan, bronchoscopic alveolar lavage fluid, and next-generation sequencing were used to explore latent causes. RESULTS: NSE level was elevated, chest CT scan showed high-density shadow of the left lung, bronchoscopy showed flesh-colored new organisms in the lower lobe of the left lung, BALF and NGS revealed the presence of Aspergillus. CONCLUSIONS: Elevated NSE is not a typical manifestation of lung cancer, and we should perform BALF and NGS early to determine whether there is infection with special pathogenic bacteria.


Sujet(s)
Maladies pulmonaires , Tumeurs du poumon , Aspergillose pulmonaire , Humains , Poumon/anatomopathologie , Tumeurs du poumon/anatomopathologie , Aspergillose pulmonaire/diagnostic , Aspergillose pulmonaire/anatomopathologie , Enolase
14.
Clin Lab ; 69(11)2023 Nov 01.
Article de Anglais | MEDLINE | ID: mdl-37948490

RÉSUMÉ

BACKGROUND: Carcinoembryonic antigen (CEA) is a polysaccharide complex present in the human respiratory system, which can reflect the presence of tumors in the human body and has important value in the monitoring of lung cancer [1], but sometimes serum CEA provides limited help. We reported a case of multiple consolidation of the lungs with elevated serum CEA, initially misdiagnosed as lung cancer and eventually confirmed by bronchoscopic lung biopsy as pulmonary cryptococcosis (PC). METHODS: Appropriate laboratory examination, chest computed tomography (CT) scan, and bronchoscopy lung biopsy were used to explore the latent etiology. RESULTS: CEA level was elevated, chest CT scan showed multiple consolidation of the lungs, serum cryptococcal antigen was positive, and pathological findings on bronchoscopic lung biopsy confirmed pulmonary cryptococcosis. CONCLUSIONS: Elevated CEA is not typical of lung cancer. We should also consider the possibility of specific pathogenic infection. Bronchoscopic lung biopsy is the gold standard should be performed as soon as possible to identify the lesion.


Sujet(s)
Cryptococcose , Maladies pulmonaires , Tumeurs du poumon , Humains , Tumeurs du poumon/diagnostic , Tumeurs du poumon/anatomopathologie , Antigène carcinoembryonnaire , Poumon/imagerie diagnostique , Poumon/anatomopathologie , Cryptococcose/diagnostic , Erreurs de diagnostic
15.
Clin Lab ; 69(10)2023 Oct 01.
Article de Anglais | MEDLINE | ID: mdl-37844045

RÉSUMÉ

BACKGROUND: Acute Eosinophilic Pneumonia (AEP) is a rare form of non-infectious pneumonia that is easily missed and misdiagnosed because of its atypical clinical symptoms and misleading laboratory and imaging studies. METHODS: By reporting a case of an initial diagnosis of lung abscess, which was treated with antibiotics and then CT suggesting that the lesion continued to worsen, it was eventually confirmed to be AEP by lung biopsy, A joint literature analysis was conducted to improve clinicians' understanding of the diagnosis and treatment of AEP. RESULTS: Initially, because of the atypical ancillary findings, we thought the disease was a lung abscess, which was eventually confirmed by pathology as AEP. CONCLUSIONS: The presence of AEP needs to be considered when various laboratory findings point to infectious dis-ease, but anti-infection is not effective. Diagnosis can be confirmed by bronchoalveolar lavage and lung tissue biopsy. Prompt treatment can provide rapid relief and reduce the risk of patient death.


Sujet(s)
Abcès du poumon , Poumon éosinophile , Humains , Poumon éosinophile/diagnostic , Poumon éosinophile/traitement médicamenteux , Poumon éosinophile/anatomopathologie , Abcès du poumon/diagnostic , Abcès du poumon/complications , Maladie aigüe , Poumon/imagerie diagnostique , Poumon/anatomopathologie , Liquide de lavage bronchoalvéolaire
16.
Clin Lab ; 69(9)2023 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-37702676

RÉSUMÉ

BACKGROUND: Current studies have reported that it is rare for the coronavirus disease 2019 (COVID-19) to be combined with two fungal infections and that COVID-19 can be combined with multiple cardiovascular complications, both of which can complicate the condition and increase the risk of death. METHODS: We report a case of COVID-19 in which Aspergillus fumigatus and Cryptococcus neoformans were detected by sputum targeted next-generation sequencing (tNGS) and cardiac monitoring during treatment revealed cardiovascular complications. RESULTS: We consider that this patient's fungal infection was associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the application of corticosteroids. In addition, cardiovascular complications were associated with an inflammatory response and increased sympathetic stimulation due to SARS-CoV-2 infection. CONCLUSIONS: The presence of COVID-19-associated fungal infections cannot be excluded when multiple risk factors for fungal infections are present in patients with COVID-19 and the condition is rapidly deteriorating. Effective long-term monitoring of cardiac function during the patient's hospitalization is necessary to reduce morbidity and mortality.


Sujet(s)
COVID-19 , Cryptococcose , Défaillance cardiaque , Humains , COVID-19/complications , Aspergillus fumigatus , SARS-CoV-2 , Défaillance cardiaque/diagnostic
17.
Clin Lab ; 69(6)2023 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-37307106

RÉSUMÉ

BACKGROUND: Tuberculosis (TB) is a common infectious disease in developing countries. Tuberculosis and sarcoidosis are difficult to differentiate. We report a case of a patient who was initially misdiagnosed as tuberculosis due to positive tuberculin test (PPD test) and tuberculosis antibody (TB-Ab), which was eventually proven as sarcoidosis by thoracoscopy. METHODS: Appropriate laboratory tests are carried out and a chest CT scan, bronchoscopy, thoracoscopic pathological biopsy were done. RESULTS: Serum sedimentation was increased and tuberculosis antibody was positive. The chest CT scan showed multiple pulmonary nodules in both lungs. The bronchoscopy demonstrated no abnormality. Thoracoscopic pathology showed noncaseating granulomas and acid-fast staining was negative. CONCLUSIONS: When a patient has multiple pulmonary nodules and lymphadenopathy without obvious tuberculosis poisoning symptoms, physicians should pay attention to tuberculosis, sarcoidosis, and lung cancer. Pathology is crucial for the ultimate diagnosis.


Sujet(s)
Nodules pulmonaires multiples , Sarcoïdose , Tuberculose , Humains , Tuberculine , Anticorps , Thoracoscopie , Erreurs de diagnostic
18.
Clin Lab ; 69(5)2023 May 01.
Article de Anglais | MEDLINE | ID: mdl-37145075

RÉSUMÉ

BACKGROUND: Infectious pulmonary diseases caused by nontuberculous mycobacteria (NTM) are becoming more common in clinical work, and early detection of the bacterium and its early identification are prerequisites for accurate treatment. METHODS: By reporting a case of confirmed NTM infection in a patient with connective tissue disease-associated interstitial lung fibrosis, a joint literature analysis was performed to improve clinicians' understanding of NTM and the clinical application of targeted next-generation sequencing (tNGS). RESULTS: Chest CT suggested a partially enlarged cavitary lesion in the upper lobe of the right lung, combined with positive sputum antacid staining, and sputum tNGS was sent to confirm the final diagnosis of Mycobacterium paraintracellulare infection. CONCLUSIONS: The successful application of tNGS helps in the rapid diagnosis of NTM infection. It also reminds medical practitioners to consider the presence of NTM infection in advance in the presence of many NTM infection factors, combined with imaging manifestations.


Sujet(s)
Maladies du tissu conjonctif , Infections à mycobactéries non tuberculeuses , Mycobacterium , Humains , Infections à mycobactéries non tuberculeuses/complications , Infections à mycobactéries non tuberculeuses/diagnostic , Mycobactéries non tuberculeuses , Fibrose
19.
Clin Lab ; 69(4)2023 Apr 01.
Article de Anglais | MEDLINE | ID: mdl-37057927

RÉSUMÉ

BACKGROUND: Organizing pneumonia is a non-specific inflammatory response to various types of damage to the lungs. It is usually considered bacterial pneumonia that has not been absorbed for more than 4 weeks, accompanied by granulomas and fibrosis. Lung lesions in patients with organizing pneumonia are usually irreversible and the prognosis is relatively poor. Coxiella burnetii can cause Q fever. Acute Q fever usually presents as a self-limiting febrile illness with a good prognosis, but there are few cases of coexisting organizing pneumonia. We report a case of organizing pneumonia secondary to Coxiella burnetii infection. METHODS: Percutaneous lung biopsy, Next-generation sequencing (NGS). RESULTS: Percutaneous lung biopsy showed the existence of organizing pneumonia, and external examination of NGS showed the existence of Coxiella burnetii infection. After symptomatic treatment with azithromycin and glucocorticoids, the patient improved and was discharged from the hospital. CONCLUSIONS: For lesions with obvious heterogeneous enhancement on chest CT imaging, percutaneous lung biopsy or bronchoscopy should be performed promptly to obtain pathological tissue, and NGS should be used for definite diagnosis if necessary.


Sujet(s)
Coxiella burnetii , Pneumonie organisée , Pneumopathie infectieuse , Fièvre Q , Humains , Fièvre Q/complications , Fièvre Q/diagnostic , Fièvre Q/traitement médicamenteux , Pneumopathie infectieuse/diagnostic , Poumon/imagerie diagnostique , Poumon/anatomopathologie
20.
Clin Lab ; 69(4)2023 Apr 01.
Article de Anglais | MEDLINE | ID: mdl-37057934

RÉSUMÉ

BACKGROUND: Pulmonary tuberculosis presenting as solitary pulmonary nodules in imaging is sometimes difficult to differentiate from lung cancer and is more likely to be misdiagnosed when accompanied by elevated CEA and positive PET-CT findings. METHODS: By reporting a case of misdiagnosed lung cancer, which was confirmed to be pulmonary tuberculosis by lung biopsy, a joint literature analysis was performed to raise clinicians' awareness of isolated nodules in the lung. RESULTS: With a series of ancillary tests, we initially considered the nodule to be malignant, and the lung biopsy pathology eventually confirmed pulmonary tuberculosis. CONCLUSIONS: When chest imaging suggests the presence of malignant features in solitary pulmonary nodules, invasive procedures can be performed appropriately to clarify the nature of the lesion. The diagnosis cannot be made blindly to ensure that no incorrect diagnosis is made nor wrong treatment given.


Sujet(s)
Tumeurs du poumon , Nodule pulmonaire solitaire , Tuberculose pulmonaire , Humains , Tomographie par émission de positons couplée à la tomodensitométrie/méthodes , Nodule pulmonaire solitaire/diagnostic , Nodule pulmonaire solitaire/anatomopathologie , Fluorodésoxyglucose F18 , Tumeurs du poumon/imagerie diagnostique , Tumeurs du poumon/anatomopathologie , Tuberculose pulmonaire/imagerie diagnostique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE